Emory Vaccine and Treatment Evaluation Unit - DMID 20-0034

NIH Pandemic-Era Grants

Pandemic Era Grants

2021

↗ Live URL (may be dead)

Document text

Principal Investigator: EVAN J ANDERSON
Organization: EMORY UNIVERSITY
Fiscal Year: 2021
Award: $669,970
Funding agency: National Institute of Allergy and Infectious Diseases

Summary/Abstract
The Emory VTEU has proven essential in the fight against the pandemic. This supplement will
allow for further investigations into second generation vaccines trials (20-0034).
1

Terms: <2019-nCoV vaccine><21+ years old><Adenoviridae><Adenoviruses><Adult><Adult Human><COVID-19 vaccine><COVID19 vaccine><Chimp><Chimpanzee><Evaluation><Generations><Investigation><Messenger RNA><Pan Genus><Pan Species><Preventative vaccine><Preventive vaccine><Prophylactic vaccine><SARS-CoV-2 vaccine><SARS-CoV2 vaccine><SARS-coronavirus-2 vaccine><Safety><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe acute respiratory syndrome coronavirus 2 vaccine><Vaccines><adulthood><corona virus disease 2019 vaccine><coronavirus disease 2019 vaccine><fight against><immunogenicity><mRNA><pandemic><pandemic disease><phase 1 trial><phase I trial><vaccination study><vaccination trial><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine for novel coronavirus><vaccine study><vaccine trial>